Liane F. Moura

Lisbon, 1649003, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Harnessing the power of microbiome, nanotechnology, and immunity against cancer.

Harnessing the power of microbiome, nanotechnology, and immunity against cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 22, 2025

Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment.

Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: February 21, 2025

Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy.

Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy.

Journal: Advanced functional materials

Published: January 29, 2024

Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors.

Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 13, 2023

Diabetes and Cannabinoid CB1 receptor deficiency promote similar early onset aging-like changes in the skin.

Diabetes and Cannabinoid CB1 receptor deficiency promote similar early onset aging-like changes in the skin.

Journal: Experimental gerontology

Published: May 23, 2021

Preclinical models and technologies to advance nanovaccine development.

Preclinical models and technologies to advance nanovaccine development.

Journal: Advanced drug delivery reviews

Published: January 26, 2021

Transient gain of function of cannabinoid CB1 receptors in the control of frontocortical glucose consumption in a rat model of Type-1 diabetes.

Transient gain of function of cannabinoid CB1 receptors in the control of frontocortical glucose consumption in a rat model of Type-1 diabetes.

Journal: Brain research bulletin

Published: March 04, 2020

Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.

Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 30, 2019

Chronic insulinopenia/hyperglycemia decreases cannabinoid CB1 receptor density and impairs glucose uptake in the mouse forebrain.

Chronic insulinopenia/hyperglycemia decreases cannabinoid CB1 receptor density and impairs glucose uptake in the mouse forebrain.

Journal: Brain research bulletin

Published: October 21, 2018

Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators.

Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators.

Journal: Nature nanotechnology

Published: April 24, 2018

α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma.

α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma.

Journal: Acta biomaterialia

Published: March 16, 2018

Poly-glutamic dendrimer-based conjugates for cancer vaccination - a computational design for targeted delivery of antigens.

Poly-glutamic dendrimer-based conjugates for cancer vaccination - a computational design for targeted delivery of antigens.

Journal: Journal of drug targeting

Published: August 11, 2017

Showing 1-12 of 20

Last Updated: 09/26/2026